Faculty

Institution

Unit

Venue

Willscott Naugler, M.D.

Professor of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Division Of Oncological Sciences

Center For Hematologic Malignancies

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Digestive Health Center

Division Of Hematology/Medical Oncology

Division of Gastroenterology & Hepatology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Willscott Naugler, M.d. is currently serving as a Biostatistics Shared Resources Professor of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Willscott Naugler, M.D.

Oregon Health & Science University

Professor of Medicine

You can click a keyword to filter the displayed items

hepatology liver transplantation oncology hepatocellular carcinoma liver cancer medicine pathology liver physiology cancer research organ transplantation clinical transplantation liver disease cell biology surgical oncology gastroenterology cancer care solid organ transplantation developmental biology tumor biology hematology digestive diseases vascular biology acute liver failure transplantation medicine tissue (biology) stem cell research clinical gastroenterology fatty liver disease radiation therapy molecular cancer leukemia virus research oncogenes cell metabolism symptom management palliative medicine alcohol-related liver disease cancer biology cancer genomics insulin signaling viral hepatitis graft survival biliary tract cancer genetics cancer risk symptom distress united network brain tumor research endocrine-related cancers mixed-phenotype acute leukemia immunosuppression adaptive immune system cancer immunosurveillance innate immune system cytokines chronic inflammation cell growth fibroblast growth factors cancer-associated virus malignant disease treatment effects hematological malignancies diet-induced inflammation insulin resistance insulin-receptor substrates jnk-mediated phosphorylation insulin gene transcription aav integration humanized livers epstein-barr virus aav gene therapy liver injury malignant infiltration obese patients higher mortality hematologic malignancies hepatitis gynecologic oncology gastrointestinal endoscopy digestive endoscopy carcinogenesis cancer discovery thoracic oncology breast cancer kidney cancer translational research surgical pathology lung cancer jama oncology gynecologic cancers anatomical pathology cancer cells radiation oncology translational medicine molecular gastroenterology ovarian cancer cancer letter tumor microenvironment gastrointestinal surgery metastasis pancreatitis sarcoma cancer imaging histopathology internal medicine mesothelioma

Notable Scholarly Works

Notable Federal Grants

Collaborators

Elective Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhosis Improves Body Composition and Function: Pilot Randomized Trial. CardioVascular and Interventional Radiology (2026)

hepatologymedicinegastroenterologyliver physiologysurgerygastrointestinal surgeryliver diseasepilot randomized trialhepatobiliary tumorshealth sciences

MO1229: Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in the Us: A 5-Year Analysis of Calid Database. Gastroenterology (2025)

hepatologychronic diseasesmedicinegastroenterologyclinical epidemiologybiliary cancerbiliary disorderhealth sciencesepidemiology

Prognostic Performance of Model for End-Stage Liver Disease (Meld) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation. CardioVascular and Interventional Radiology (2025)

hepatologytranslational medicinemedicinegastroenterologyliver transplantationoncologyliver physiologysurgeryend-stage liver diseaseacute liver failureliver diseasehepatobiliary tumorsprognostic performance

Safety and Feasibility of Stereotactic Body Radiation Therapy for Patients With Hepatocellular Carcinoma and Advanced Cirrhosis Awaiting Liver Transplantation: A Prospective Pilot Clinical Trial. International Journal of Radiation Oncology*Biology*Physics (2025)

hepatologyorgan transplantationliver transplantationclinical transplantationradiation therapyoncologyradiation oncologysurgeryliver cancerradiationhepatocellular carcinomaclinical radiation oncology

The Current Status of CMV Prophylaxis and Treatment in Liver Transplant Recipients: A Single Center Study. Journal of Liver Transplantation (2025)

hepatologyorgan transplantationmedicineliver transplantationclinical transplantationcurrent statusinfectious diseasesinfectious diseases (medical specialty)cmv prophylaxissolid organ transplantationtransplant infectious diseasesliver transplant recipientstransplantation medicine

The Fate of Anti-Hla Antibodies Following Liver Transplantation. Frontiers in Nephrology (2024)

hepatologyliver transplantationorgan transplantationclinical transplantationimmunologycell transplantationsolid organ transplantationhla typinghistocompatibility

Bridge-To-Transplant Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Advanced Cirrhosis.. Journal of Clinical Oncology (2022)

hepatologyliver transplantationclinical transplantationradiation therapyoncologyradiation oncologysurgeryliver cancerradiationadvanced cirrhosishepatocellular carcinoma

Plasma Cell-Free Rna Profiling Distinguishes Cancers From Pre-Malignant Conditions in Solid and Hematologic Malignancies. npj Precision Oncology (2022)

Breeshey Roskams-HieterHyun Ji KimPavana AnurJosiah T. WagnerRowan CallahanElias SpiliotopoulosCharles Ward KirschbaumFehmi CivitciPaul T. SpellmanReid F. ThompsonKhashayar FarsadWillscott E. NauglerThuy T. M. Ngo

hematologycancer genomicscancer researchoncologyhematological malignanciescancer biologyimmunologyhematologic malignanciespre-malignant conditions

Aav Integration in Human Hepatocytes. Molecular Therapy (2021)

hepatologyvirologyliver physiologyviral hepatitismedical virologycell biologygene therapyaav integration

In Vitro Expansion of Cirrhosis Derived Liver Epithelial Cells With Defined Small Molecules. Stem Cell Research (2021)

Bin LiYuhan WangCarl PelzJosh MossRuth ShemerYuval DorYassmine K. AkkariPamela S. CanadyWillscott E. NauglerSusan OrloffMarkus Grompe

developmental biologyhepatologystem cell researchliver physiologycellular differentiationstem cellscell biologyliver cancertissue developmentbmp pathwaysepithelial cellsliver diseasetissue (biology)gene expressionorgan development

1
2
3
4
5
6
10 / page

Willscott Naugler, M.D.

Professor of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Division Of Oncological Sciences

Center For Hematologic Malignancies

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Digestive Health Center

Division Of Hematology/Medical Oncology

Division of Gastroenterology & Hepatology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Willscott Naugler, M.d. is currently serving as a Biostatistics Shared Resources Professor of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Willscott Naugler, M.D.

Oregon Health & Science University

Professor of Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Elective Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhosis Improves Body Composition and Function: Pilot Randomized Trial. CardioVascular and Interventional Radiology (2026)

hepatologymedicinegastroenterologyliver physiologysurgerygastrointestinal surgeryliver diseasepilot randomized trialhepatobiliary tumorshealth sciences

MO1229: Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in the Us: A 5-Year Analysis of Calid Database. Gastroenterology (2025)

hepatologychronic diseasesmedicinegastroenterologyclinical epidemiologybiliary cancerbiliary disorderhealth sciencesepidemiology

Prognostic Performance of Model for End-Stage Liver Disease (Meld) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation. CardioVascular and Interventional Radiology (2025)

hepatologyorgan transplantationliver transplantationclinical transplantationradiation therapyoncologyradiation oncologysurgeryliver cancerradiationhepatocellular carcinomaclinical radiation oncology

The Current Status of CMV Prophylaxis and Treatment in Liver Transplant Recipients: A Single Center Study. Journal of Liver Transplantation (2025)

The Fate of Anti-Hla Antibodies Following Liver Transplantation. Frontiers in Nephrology (2024)

hepatologyliver transplantationorgan transplantationclinical transplantationimmunologycell transplantationsolid organ transplantationhla typinghistocompatibility

Bridge-To-Transplant Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Advanced Cirrhosis.. Journal of Clinical Oncology (2022)

hepatologyliver transplantationclinical transplantationradiation therapyoncologyradiation oncologysurgeryliver cancerradiationadvanced cirrhosishepatocellular carcinoma

Plasma Cell-Free Rna Profiling Distinguishes Cancers From Pre-Malignant Conditions in Solid and Hematologic Malignancies. npj Precision Oncology (2022)

hematologycancer genomicscancer researchoncologyhematological malignanciescancer biologyimmunologyhematologic malignanciespre-malignant conditions

Aav Integration in Human Hepatocytes. Molecular Therapy (2021)

hepatologyvirologyliver physiologyviral hepatitismedical virologycell biologygene therapyaav integration

In Vitro Expansion of Cirrhosis Derived Liver Epithelial Cells With Defined Small Molecules. Stem Cell Research (2021)

Bin LiYuhan WangCarl PelzJosh MossRuth ShemerYuval DorYassmine K. AkkariPamela S. CanadyWillscott E. NauglerSusan OrloffMarkus Grompe

1
2
3
4
5
6
10 / page